Primary results from PATRICIA cohort C (SOLTI-1303), a randomized phase II study evaluating palbociclib with trastuzumab and endocrine therapy in pretreated HER2-positive and PAM50 luminal advanced breast cancer.Eva Ciruelos, Aleix Prat, Guillermo Villacampa et al.|Journal of Clinical Oncology|2024Cited by 8